KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.96
-0.09 (-0.99%)
Nov 20, 2024, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $387.21 million as of November 21, 2024. Its market cap has increased by 32.42% in one year.
Market Cap
387.21M
Enterprise Value
219.19M
1-Year Change
32.42%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $387.21M, an increase of 199.47%. That is a compound annual growth rate of 12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 391.10M | -7.61% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 423.07M |
| Revance Therapeutics | 418.56M |
| DocGo | 408.20M |
| Contineum Therapeutics | 408.06M |
| Prime Medicine | 405.75M |
| Rigel Pharmaceuticals | 400.57M |
| Canopy Growth | 398.27M |
| Sangamo Therapeutics | 396.43M |